BTIG Reiterates Neutral Rating on Senseonics Holdings (SENS)

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/27/2026

1. ORCL
2. SPY
3. ANT
4. FFAI
5. FFR
6. LLY
7. TSLA
8. META
9. FICO
10. CART

Go back to BTIG Reiterates Neutral Rating on Senseonics Holdings (SENS)

Eversense 365 Receives FDA Clearance: The World’s First One Year CGM

September 17, 2024 7:00 AM EDT

Eversense 365 cleared in the U.S. as an integrated continuous glucose monitoring (iCGM) system for people with diabetes

With a single sensor, the Eversense 365 system provides one year of use, versus 10-14 days with short-term CGMs for minimal life disruption

Launch expected early in the fourth quarter of 2024

GERMANTOWN, Md. & PARSIPPANY, N.J.--(BUSINESS WIRE)-- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose... More